Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Coronavirus company news summary – Abbott begins delivering BinaxNOW Covid-19 Ag self-test to retailers – Therma Bright receives CE approval for Covid-19 rapid antigen saliva test

20 Apr 2021 (Last Updated April 20th, 2021 10:04)

Abbott has started delivering its BinaxNOW Covid-19 Ag Self-Test to retailers across the US. The test is expected to be available to customers on online platforms and at some retail stores such as CVS Pharmacy, Walmart, and Walgreens without a prescription. The self-test will be more broadly available in the upcoming two weeks. The company manufactures millions of self-tests per month and is looking at scaling capacity based on demand.

Therma Bright has received CE mark approval for its AcuVid Covid-19 rapid antigen saliva test. The company has also secured a conditional purchase order for 100,000 units through McWilliams Collective, a new global distribution partner. The order is secured for a large European client, on conditions that the company provides the initial test data which demonstrates 86%+ specificity and 100% sensitivity, and that the production levels are reached and delivered in June 2021.

RICOVR Healthcare has raised $1.5m to fund the commercialisation of its point-of-care testing device for both tetrahydrocannabinol (THC), a psychoactive constituent of cannabis, and Covid-19 disease. The company’s biosensor platform allows a small saliva sample to deliver results within just five minutes. The funding is expected to support the go-to-market goals for the XALIVA platform.